Atorvastatin Calcium
Product Images NDC 68071-2439

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Chemical structure of atorvastatin calcium dihydrate, showing the molecular arrangement including two atorvastatin moieties complexed with calcium and three water molecules.*

FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

A line graph comparing cumulative incidence percentages over approximately 3.5 years for Atorvastatin and placebo groups. The graph shows two lines indicating lower cumulative incidence for Atorvastatin versus placebo. It includes a hazard ratio of 0.64 (0.50-0.83) with a p-value of 0.0005, illustrating a statistical analysis of the data.*

FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

A Kaplan-Meier cumulative hazard curve comparing Atorvastatin versus Placebo over a follow-up period of up to 4 years. The x-axis shows time to first primary endpoint in years, and the y-axis represents cumulative hazard percentage. The graph includes a hazard ratio (HR) of 0.63 (0.48-0.83) with a p-value of 0.001, indicating statistical data from a clinical study.*

FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between two dosages of atorvastatin calcium: 10 mg and 80 mg. The x-axis represents time in years up to 5 years, and the y-axis shows the percentage of subjects. The graph indicates a lower event rate for the 80 mg dosage with a hazard ratio of 0.78 (0.69-0.89) and statistical significance (P=0.0002).*

FDA Label Image

Pdp (68071 2439 9)

Packaging label for Atorvastatin Calcium 40mg tablets, containing 90 tablets per bottle. The label includes NDC 68071-2439-9, manufacturer Lupin Limited Nagpur-441108 India, and labeler NuCare Pharmaceuticals, Inc., Orange, CA 92867. It features product and lot information, storage instructions at 68-77°F, and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.